FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078558213> ?p ?o ?g. }

• W2078558213 endingPage "6468" @default.
• W2078558213 startingPage "6459" @default.
• W2078558213 abstract "Abstract Purpose: Inhibitors of heat-shock protein 90 (Hsp90) may interfere with oncogenic signaling pathways, including Erk, Akt, and hypoxia-inducible factor-1α (HIF-1α). Because insulin-like growth factor-I receptor (IGF-IR) and signal transducer and activator of transcription 3 (STAT3) signaling pathways are implicated in the progression of pancreatic cancer, we hypothesized that blocking Hsp90 with geldanamycin derivates [17-allylamino-geldanamycin (17-AAG), 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG)] would impair IGF-I– and interleukin-6–mediated signaling and thus reduce pancreatic tumor growth and angiogenesis in vivo. Experimental Design: Human pancreatic cancer cells (HPAF-II, L3.6pl) were used for experiments. Changes in signaling pathway activation upon Hsp90 blockade were investigated by Western blotting. Effects of Hsp90 inhibition (17-AAG) on vascular endothelial growth factor were determined by ELISA and real-time PCR. Effects of 17-DMAG (25 mg/kg; thrice a week; i.p.) on tumor growth and vascularization were investigated in a s.c. xenograft model and in an orthotopic model of pancreatic cancer. Results: 17-AAG inhibited IGF-IR signaling by down-regulating IGF-IRβ and directly impairing IGF-IR phosphorylation. Hypoxia- and IL-6–mediated activation of HIF-1α or STAT3/STAT5 were substantially inhibited by 17-AAG. Moreover, a novel IL-6/STAT3/HIF-1α autocrine loop was effectively disrupted by Hsp90 blockade. In vivo, 17-DMAG significantly reduced s.c. tumor growth and diminished STAT3 phosphorylation and IGF-IRβ expression in tumor tissues. In an orthotopic model, pancreatic tumor growth and vascularization were both significantly reduced upon Hsp90 inhibition, as reflected by final tumor weights and CD31 staining, respectively. Conclusions: Blocking Hsp90 disrupts IGF-I and IL-6–induced proangiogenic signaling cascades by targeting IGF-IR and STAT3 in pancreatic cancer, leading to significant growth-inhibitory effects. Therefore, we suggest that Hsp90 inhibitors could prove to be valuable in the treatment of pancreatic cancer." @default.
• W2078558213 created "2016-06-24" @default.
• W2078558213 creator A5006359197 @default.
• W2078558213 creator A5007121961 @default.
• W2078558213 creator A5019329875 @default.
• W2078558213 creator A5021975495 @default.
• W2078558213 creator A5022678280 @default.
• W2078558213 creator A5024998614 @default.
• W2078558213 creator A5042960013 @default.
• W2078558213 creator A5043305493 @default.
• W2078558213 creator A5067227229 @default.
• W2078558213 creator A5083749444 @default.
• W2078558213 creator A5087276676 @default.
• W2078558213 date "2007-11-01" @default.
• W2078558213 modified "2023-09-27" @default.
• W2078558213 title "Targeting Heat Shock Protein 90 in Pancreatic Cancer Impairs Insulin-like Growth Factor-I Receptor Signaling, Disrupts an Interleukin-6/Signal-Transducer and Activator of Transcription 3/Hypoxia-Inducible Factor-1α Autocrine Loop, and Reduces Orthotopic Tumor Growth" @default.
• W2078558213 cites W1971190195 @default.
• W2078558213 cites W1972045191 @default.
• W2078558213 cites W1978598058 @default.
• W2078558213 cites W1980679718 @default.
• W2078558213 cites W1981000484 @default.
• W2078558213 cites W1981072187 @default.
• W2078558213 cites W1982317652 @default.
• W2078558213 cites W1988692190 @default.
• W2078558213 cites W1989657978 @default.
• W2078558213 cites W1994372793 @default.
• W2078558213 cites W1996102081 @default.
• W2078558213 cites W1998177819 @default.
• W2078558213 cites W2000929246 @default.
• W2078558213 cites W2004792969 @default.
• W2078558213 cites W2007856734 @default.
• W2078558213 cites W2009899654 @default.
• W2078558213 cites W2024233733 @default.
• W2078558213 cites W2038905417 @default.
• W2078558213 cites W2042702886 @default.
• W2078558213 cites W2053298425 @default.
• W2078558213 cites W2058301168 @default.
• W2078558213 cites W2058426917 @default.
• W2078558213 cites W2065339586 @default.
• W2078558213 cites W2071696750 @default.
• W2078558213 cites W2095818256 @default.
• W2078558213 cites W2098096093 @default.
• W2078558213 cites W2098243292 @default.
• W2078558213 cites W2100288953 @default.
• W2078558213 cites W2102392020 @default.
• W2078558213 cites W2115974767 @default.
• W2078558213 cites W2117904830 @default.
• W2078558213 cites W2121394959 @default.
• W2078558213 cites W2130548814 @default.
• W2078558213 cites W2137374006 @default.
• W2078558213 cites W2144888252 @default.
• W2078558213 cites W2149612371 @default.
• W2078558213 cites W2153949698 @default.
• W2078558213 cites W2157600501 @default.
• W2078558213 cites W2159166087 @default.
• W2078558213 cites W2168267246 @default.
• W2078558213 cites W2170189698 @default.
• W2078558213 cites W4252424774 @default.
• W2078558213 doi "https://doi.org/10.1158/1078-0432.ccr-07-1104" @default.
• W2078558213 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17975158" @default.
• W2078558213 hasPublicationYear "2007" @default.
• W2078558213 type Work @default.
• W2078558213 sameAs 2078558213 @default.
• W2078558213 citedByCount "129" @default.
• W2078558213 countsByYear W20785582132012 @default.
• W2078558213 countsByYear W20785582132013 @default.
• W2078558213 countsByYear W20785582132014 @default.
• W2078558213 countsByYear W20785582132015 @default.
• W2078558213 countsByYear W20785582132016 @default.
• W2078558213 countsByYear W20785582132017 @default.
• W2078558213 countsByYear W20785582132018 @default.
• W2078558213 countsByYear W20785582132019 @default.
• W2078558213 countsByYear W20785582132020 @default.
• W2078558213 countsByYear W20785582132021 @default.
• W2078558213 countsByYear W20785582132022 @default.
• W2078558213 countsByYear W20785582132023 @default.
• W2078558213 crossrefType "journal-article" @default.
• W2078558213 hasAuthorship W2078558213A5006359197 @default.
• W2078558213 hasAuthorship W2078558213A5007121961 @default.
• W2078558213 hasAuthorship W2078558213A5019329875 @default.
• W2078558213 hasAuthorship W2078558213A5021975495 @default.
• W2078558213 hasAuthorship W2078558213A5022678280 @default.
• W2078558213 hasAuthorship W2078558213A5024998614 @default.
• W2078558213 hasAuthorship W2078558213A5042960013 @default.
• W2078558213 hasAuthorship W2078558213A5043305493 @default.
• W2078558213 hasAuthorship W2078558213A5067227229 @default.
• W2078558213 hasAuthorship W2078558213A5083749444 @default.
• W2078558213 hasAuthorship W2078558213A5087276676 @default.
• W2078558213 hasConcept C104317684 @default.
• W2078558213 hasConcept C121608353 @default.
• W2078558213 hasConcept C126322002 @default.
• W2078558213 hasConcept C128240485 @default.
• W2078558213 hasConcept C134018914 @default.
• W2078558213 hasConcept C167734588 @default.
• W2078558213 hasConcept C170493617 @default.
• W2078558213 hasConcept C171958077 @default.
• W2078558213 hasConcept C205260736 @default.
• W2078558213 hasConcept C2775932338 @default.

• next